This application is a U.S. national counterpart application of International Application Serial No. PCT/EP2017/063147, filed May 31, 2017, under 35 U.S.C. § 371, which claims priority to GB Application Serial No. 1610063.8, filed Jun. 9, 2016, the disclosures of which are hereby incorporated herein by reference.
The present invention relates to composite products manufactured using a binder composition which comprises a carbohydrate component, possibly a crosslinker, possibly reaction product of carbohydrate component and crosslinker; it also relates to such binders obtained from said binder composition.
While known carbohydrate based binders and composite material made therewith show interesting mechanical properties, there always is a need to further improve said properties, more specifically under humid or wet conditions.
In accordance with one of its aspects, the present invention provides a binder composition as defined in claim 1. Further aspects are defined in other independent claims. The dependent claims define preferred or alternative embodiments.
The term “binder composition” as used herein means all ingredients applied to the matter to be bound and/or present on the matter to be bound, notably prior to curing, (other than the matter and any moisture contained within the matter) including reactants, solvents (including water), any carbohydrate component, any crosslinker and any additives.
The term “binder” is used herein to designate a thermoset binder resin obtained from the “binder composition”.
The term “cured” means that the components of the binder composition have been subjected to conditions that lead to chemical change, such as covalent bonding, hydrogen bonding and chemical crosslinking, which may increase the cured product's durability and solvent resistance, and result in thermoset material.
The term “dry weight of the binder composition” as used herein means the weight of all components of the binder composition other than any water that is present (whether in the form of liquid water or in the form of water of crystallization).
The term “carbohydrate component” as used herein means a carbohydrate or derivative thereof, including monosaccharides, disaccharides, oligosaccharides and polysaccharides. Examples are glucose, fructose, xylose, sucrose, maltose, trehalose, sorbitol, dextrines, maltodextrins, amylose, amylopectine, starch, modified starches, cellulose, hemicellulose, and pectins, hydrolysis products thereof, precursors thereof that form the relevant carbohydrates or derivatives thereof in situ, and mixtures thereof. The carbohydrate component may be a reducing sugar reactant or a non-reducing sugar that generates a reducing sugar in situ.
The term “crosslinker” as used herein comprises compounds that are capable of reacting with the carbohydrate component to form ramifications or reticulations of the said carbohydrate component.
Phenalkamines are known as curing agents and may be obtained by the reaction of an alkylphenol with aliphatic polyamines and formaldehyde. The polyamine advantageously is an amine having two or more primary amine functionalities, possibly substituted with additional secondary amine functionalities.
A preferred phenalkamine shows the general formula below
wherein
R1 is a straight or branched, saturated or unsaturated alkyl group comprising 12 to 24 C-atoms
R2 and R3 are linear or branched alkanediyl having 2 to 20 C-atoms, cycloaliphatic groups or contain aromatic groups and
x is an integer ranging from 0 to 5 and y is an integer ranging from 1 to 5.
Suitable polyamines for reaction with alkylphenol and formaldehyde show the general formula
H2N—((—R2—NH—)x—R3—)y—NH2
wherein R2 and R3 are linear or branched alkanediyl having 2 to 20 C-atoms, cycloaliphatic groups or contain aromatic groups, and x is an integer ranging from 0 to 5 and y is an integer ranging from 1 to 5.
Examples of polyamines include, but are not limited to: ethyleneamines such as 1,2-ethanediamine (EDA), N-(2-aminoethyl)-1,2-ethanediamine (DETA), N,N-bis(2-amino-ethyl)-I,2-ethanediamine (TETA), N-(2-aminoethyl)-N′-[(2-amino-ethyl)amino-ethyl]-I,2-ethanediamine (TEPA), aminoethylpiperazine, and higher polyethylenepolyamines, 1,3-benzenedimethanamine (MXDA—metaxylylene diamine); 1,3-cyclohexanedimethanamine (1,3-BAC); 1,2-diaminocyclohexane (DACH); norbornanediamine; isophorone diamine; 5-amino-I,3,3-trimethylcyclo-hexanemethanamine (IPDA); trimethylhexamethylenediamine (TMD); 1,3-pentanediamine; 2-methyl-I,5-pentanediamine; 1,6-hexanediamine (HMDA) and 4,4′-diaminodicyclohexylmethane (PACM).
The binder composition may be used in the manufacturing of composite products, such as wood boards, for example wood particle boards, medium density fibreboard (MDF), chip boards or orientated strand board (OSB), and plywood. The binder may be used to bond abrasive particles together and/or onto a backing sheet or to bond fibers, such as woven and non-woven natural, synthetic, textile or mineral fibers, for instance glass fibers or mineral wool fibers. Such bonded mineral fibers, for instance mineral glass wool or stone wool fibers, may be used in the manufacturing of thermal and/or acoustic insulating materials.
A wood particle board is a composite material manufactured from wood particles, for example wood chips, sawmill shavings and/or saw dust at varying particle sizes held together by a binder and used especially for the manufacture of furniture, such as cabinets, kitchens and bathroom furniture. Generally, wood particle board (which is sometimes referred to as “chipboard”) is produced by mixing wood particles and a binder composition, e.g. a thermo-curable resin, subsequently forming the resulting mixture into a sheet or mat and compressing said sheet or mat under elevated temperatures.
Plywood is a composite sheet material manufactured from thin layers of wood glued together by a binder, adjacent wood layers having their wood grain rotated by approx. 90 degrees to one another.
When used as a binder in wood boards, such as plywood, particle boards, fiber boards, the solid content of the aqueous binder composition may range from 50 to 95 w %, preferably 50 to 90 w %, more preferably 55 to 85 w % or even 60 to 80 w %, based upon the weight of the total aqueous binder composition.
The binder may also be used to bond synthetic or natural fibers, for instance mineral fibers, such as glass fibers, glass wool or stone wool. In view of the manufacture of a fiber mat, such as for insulating products, for instance, an aqueous binder composition is applied onto the fibers, e.g. by spraying, and the binder impregnated mineral fibers are deposited as a mat and subsequently subjected to heat for curing of the binder composition, hence forming an assembly of bonded fibers.
When used in the manufacture of a fiber based composite, the solid content of the invention aqueous binder composition may range from 5 to 95 w %, advantageously from 8 to 90 w %, preferably from 10 to 85 w %, based on the weight of the total aqueous binder composition. More specifically, when used as a binder for mineral wool insulation, the solid content of the aqueous binder composition may be in the range from 5 to 25 w %, preferably from 8 to 20 w %, more preferably from 10 to 20 w % or even 12 to 18 w %, based on the weight of the total aqueous binder composition.
In preferred embodiments, the present invention provides improved product and/or binder performance, notably mechanical performance, under wet or humid conditions. This makes the binders particularly suitable where sensitivity to water or humidity is an important criteria, for example wood boards.
It has been found that the phenalkamine component reacts with the carbohydrate component and/or the cross-linker and confers water-resistance properties to the binder through its hydrophobic groups, and hence to the composite product incorporating said binder. As a result, the binder composition of the invention may be used to form a water-resistant silicone-free binder and composite incorporating said binder.
The crosslinker may advantageously be selected from mono- or polycarboxylic acids, including monomeric and polymeric polycarboxylic acids, such as polyacrylates, and nitrogenous components. The nitrogenous component may be selected from NH3, an inorganic amine or an organic amine comprising at least one primary amine group, as well as salts thereof. It may comprise NH3 used as such (e.g. in form of an aqueous solution), or an inorganic or organic ammonium salt, for example ammonium sulfate (AmSO4), ammonium phosphate, e.g. diammonium phosphate, ammonium chloride, ammonium nitrate or ammonium citrate. The nitrogenous component may also be a polyamine, that is any organic compound having two or more amine groups, which may independently be substituted or unsubstituted. For example, the polyamine may be a primary polyamine. As used herein, a “primary polyamine” is an organic compound having two or more primary amine groups (—NH2). Within the scope of the term primary polyamine are those compounds which can be modified in situ or isomerize to generate a compound having two or more primary amine groups (—NH2). The primary polyamine may be a molecule having the formula H2N-Q-NH2, wherein Q is an alkanediyl, cycloalkanediyl, heteroalkanediyl, or cycloheteroalkanediyl, each of which may be optionally substituted. For example, Q may be an alkanediyl group selected from —C2-C24—, an alkanediyl group selected from —C2-C9—, or an alkanediyl group selected from —C3-C7—. According to a preferred embodiment, Q is a C6 alkanediyl. According to another embodiment, Q may be a cyclohexanediyl, cyclopentanediyl or cyclobutanediyl, or a divalent benzyl radical. In this context, it should be noted that certain authors prefer using the term “alkyl” instead of the chemically more correct “alkanediyl” nomenclature; the same chemical group is meant. As used herein, the term “alkanediyl” means a chain of carbon atoms, which may optionally be branched, preferably of limited length, including —C1-C24—, —C1-C12—, —C1-C8—, —C1-C6—, and —C1-C4—. Shorter alkanediyl groups may add less lipophilicity to the compound and accordingly will have different reactivity towards the reducing sugar reactant and/or solubility.
As used herein, the term “cycloalkanediyl” means a chain of carbon atoms, which may optionally be branched, where at least a portion of the chain is cyclic and also includes polycyclic structures, for example, cyclopropanediyl, cyclopentanediyl, cyclohexanediyl, 2-methylcyclopropanediyl, 2-ethylcyclopentanediyl, adamantanediyl. Furthermore, the chain forming cycloalkanediyl is advantageously of limited length, including —C3-C24—, —C3-C12—, —C3-C8—, —C3-C6—, and —C5-C6—. Shorter alkanediyl chains forming cycloalkanediyl may add less lipophilicity to the compound and accordingly will have a different behaviour.
As used herein, the term “heteroalkanediyl” means a chain of atoms that includes both carbon and at least one heteroatom, and is optionally branched. Examples of such heteroatoms include nitrogen, oxygen, and sulfur. In certain variations, said hetero-atoms also include phosphorus, and selenium. In one embodiment, the heteroalkanediyl is a polyether. As used herein, the term “cycloheteroalkanediyl”, includes a chain of atoms that includes both carbon and at least one heteroatom, such as heteroalkanediyl, and may optionally be branched, where at least a portion of the chain is cyclic. Particularly, examples of cycloheteroalkanediyl include divalent tetrahydrofuryl, pyrrolidinyl, tetrahydropyranyl, piperidinyl, morpholinyl, piperazinyl, homopiperazinyl, quinuclidinyl.
“Optionally substituted” means the replacement of one or more hydrogen atoms with other functional groups. Such other functional groups may include amino, hydroxyl, halo, thiol, alkyl, haloalkyl, heteroalkyl, aryl, arylalkyl, arylheteroalkyl, nitro, sulfonic acids and derivatives thereof, carboxylic acids and derivatives thereof.
The primary polyamine may be a diamine, triamine, tetramine, or pentamine, for example: a triamine selected from a diethylenetriamine, 1-piperazineethanamine, or bis(hexamethylene)triamine; triethylenetetramine; or tetraethylenepentamine. One feature of the primary polyamine is that it may possess low steric hindrance. For example, 1,2-diaminoethane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,12-diaminododecane, 1,4-diaminocyclohexane, 1,4-diaminobenzene, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, 1-piperazine-ethanamine, 2-methyl-pentamethylenediamine, 1,3-pentanediamine, and bis(hexamethylene)triamine, as well as 1,8-diaminooctane have low steric hindrance.
Preferably, the nitrogenous component comprises or consists of 1,6-diaminohexane (hexamethylenediamine, HMDA) or 1,5-diamino-2-methylpentane (2-methyl-pentamethylenediamine.
In another embodiment, the nitrogenous component comprises or consists of a polyether-polyamine, which may be a diamine or a triamine, for example a trifunctional primary amine having an average molecular weight of 440 known as Jeffamine T-403 Polyetheramine (e.g. Huntsman Corporation). In yet another embodiment, the nitrogenous component may comprise or consist of a polymeric polyamine, for example chitosan, polylysine, polyethylene imine, poly(N-vinyl-N-methyl amine), polyaminostyrene, polyvinyl amine (which can be a homopolymer or a copolymer). Proteins, such as whey protein or soy protein, may also be used.
The binder composition may comprise a binder composition as described in any of WO 2007/014236, WO 2009/019232, WO 2009/019235, WO 2011/138458, WO 2011/138459 or WO 2013/150123, each of which is hereby incorporated by reference.
In the binder composition, the carbohydrate component is advantageously present in an amount ranging from 30%, preferably from 40%, preferably from 50%, more preferably from 60%, more preferably from 70%, even more preferably from 80% by dry weight of the binder composition, to less than 97% more preferably less than 95% by dry weight of the binder composition.
The crosslinker may make up:
less than 50% or 40%, preferably less than 30%, more preferably less than 25% by dry weight of the binder composition; and/or
at least 2.5%, preferably at least 5%, more preferably at least 10% by dry weight of the binder composition.
The binder composition may comprise at least 25%, and preferably at least 40%, at least 50% or at least 60% by dry weight of: (a) carbohydrate component and crosslinker and/or (b) curable reaction product(s) of carbohydrate component and crosslinker.
When the carbohydrate is a reducing sugar and the crosslinker is an amino compound, the ratio of carbonyl groups in the reducing sugar reactant(s) to reactive amino groups in the nitrogen-containing reactant(s) may be in the range of 5:1 to 1:2. For example, the ratio of carbonyl groups to reactive amino groups may be in the range of 5:1 to 1:1.8, 5:1 to 1:1.5, 5:1 to 1:1.2, 5:1 to 1:1, 5:1 to 1:0.8 and 5:1 to 1:0.5. Further examples include ratios such as 4:1 to 1:2, 3.5:1 to 1:2, 3:1 to 1:2, 2.5:1 to 1:2, 2:1 to 1:2 and 1.5:1 to 1:2. In this context, the term “reactive amino group” means any amino group in the crosslinker which is capable of reacting with the carbohydrate component. Specifically, examples of such reactive amino groups include primary and secondary amino groups, amide groups, imine and imide groups, as well as cyanate and isocyanate.
The crosslinker and the reducing sugar reactant(s) (or their reaction product(s)) may be Maillard reactants that react to form Maillard reaction products, notably melanoidins when cured. Curing of the binder composition may comprise or consist essentially of Maillard reaction(s). The cured binder is preferably a thermoset binder and is preferably substantially water insoluble.
The reducing sugar reactant may comprise: a monosaccharide, a monosaccharide in its aldose or ketose form, a disaccharide, a polysaccharide, a triose, a tetrose, a pentose, xylose, an hexose, dextrose, fructose, a heptose, a sugar, molasses, starch, starch hydrolysate, cellulose hydrolysates, reaction product(s) thereof or mixtures thereof as well as non-reducing sugars and derivatives thereof that generate a reducing sugar in situ, like sucrose or molasses. The reducing sugar reactant(s), or carbohydrate reactant(s) that yield the reducing sugar reactant(s) may have a dextrose equivalent of at least about 50, at least about 60, at least about 70, at least about 80 or at least about 90. The reducing sugar reactant may comprise or consist of high fructose corn syrup (HFCS).
The binder composition may comprise one or more adjuvants, for example waxes, dyes, dedusters, release agents and formaldehyde scavengers (notably urea, tannins, quebracho extract, ammonium phosphate bisulfite). It may further comprise, if so desired, appropriate catalysts that catalyse the reaction between carbohydrate component and crosslinker. Such catalysts may be selected from known catalysts, such phosphorous containing salts or acids. Examples are sodium hypophosphite, phosphates etc.
The binder composition is preferably free of, or comprises no more than 5 wt % or no more than 10 wt % urea formaldehyde (UF), melamine urea formaldehyde (MUF) and/or phenol formaldehyde.
The binder composition preferably does not comprise any added formaldehyde. It may be “substantially formaldehyde free”, that is to say that it liberates less than 5 ppm formaldehyde as a result of drying and/or curing (or appropriate tests simulating drying and/or curing); more preferably it is “formaldehyde free”, that is to say that it liberates less than 1 ppm formaldehyde in such conditions.
The binder composition of the invention may be applied to wood particles, abrasive particles, sheet material, or fibers, which may then be subjected to heat and/or pressure to cure the components of the binder composition in order to form a cured thermoset binder resin which holds the particles, sheet or fibers together in a composite material.
The binders of the invention may be used to bond a collection of non or loosely assembled matter. The collection of matter includes any collection of matter which comprises fibers selected from mineral fibers, slag wool fibers, stone wool fibers, glass fibers, aramid fibers, ceramic fibers, metal fibers, carbon fibers, polyimide fibers, polyester fibers, rayon fibers, and cellulosic fibers. Further examples of collection of matter include particulates such as coal, sand, cellulosic fibers, wood shavings, saw dust, wood pulp, ground wood, wood chips, wood strands, wood layers, other natural fibers, such as jute, flax, hemp, straw, wood veneers, facings and other particles, woven or non-woven materials. According to a specific embodiment of the invention, the collection of matter is selected from wood particles and mineral fibers.
In one illustrative embodiment, the binder composition of the invention may be used to make thermal insulation products, comprising mineral fibers. In such an application, the fibers are bonded together such that they become organized in a fiberglass mat which may then be processed into an insulation product. In such an application, the fibers are generally present in an amount ranging from 70 to 99% by total weight of the insulation product, notably from 80 to 99% or from 85 to 99%.
According to another embodiment of the invention, the binder may be used to bond cellulosic particles, such as cellulosic fibers, wood shavings, wood pulp and other materials commonly used to manufacture composite wood boards, including fiber boards, particle boards, oriented strand boards, plywood etc. Such wood boards show nominal thicknesses ranging from 6 to 30 mm and a modulus of Elasticity of at least about 1000 N/mm2, bending strength of at least about 5 N/mm2 and/or an internal bond strength of at least 0.10 N/mm2. In such applications, the binder content in the final wood board may range from about 5 to 30% wt with respect to the total weight of the wood board notably from 9 to 20%.
The aqueous binder composition may be applied onto the fiber or particulate material by spray application. Other possible techniques include roll application or mixing and/or tumbling the collection of matter with the binder composition. As water evaporates the binder composition may form a gel that bonds the particulate material together when arranged into a desirable assembly. When curing, the polyphenolic macromolecular compound and the polyamine functional compound are caused to react to form an essentially water insoluble macromolecular binder. Curing thus imparts increased adhesion, durability and water resistance as compared to uncured binder. Curing may be effected at temperatures between ambient and up to 280° C.
The invention will be described here below with reference to examples and Figures.
In the Figures:
As mentioned earlier, the phenalkamine component appears to confer water-resistance properties to the binder incorporating it and to composite materials made with the invention binder. The advantageous properties of invention binder compositions and composite materials will be shown in more details herein below.
Glucose and ammonium sulphate were dissolved in water individually and combined at ambient temperature under stirring such as to obtain a glucose:ammonium sulphate ratio of 85:15 wt %, based on dry weight. A fraction of the obtained composition was retained as control (control 1). Another fraction was withdrawn and 3 wt % of polydimethylsiloxane based water repellent (Basildon Chemicals BC2631 which is a co-emulsion of blended reactive polydimethylsiloxanes for use on glass wool and mineral substrates) were added (based on dry weight) to form control 2. A further fraction of the initial binder composition was withdrawn and 3 wt % phenalkamine (RAC950 supplied by Royce International) were added as a 10% dispersion in water (B1). To a further fraction, 1.5 wt % BC2631 and 1.5 wt % RAC950 as a 10% aqueous dispersion were added (B2).
The binder compositions were applied onto a glass microfiber Whatman GF/A filter as follows: the glass filter was completely submerged for 5 seconds into a binder composition, fixed with a wire. The glass filter was then withdrawn and suspended in a frame placed in a drying oven at 200° C. for 10 min. After curing, the filter was weighted. The obtained composite product (bonded glass filter) was placed into a 400 ml beaker and 200 ml water were added. A glass rod was placed on top of the filter and the filter was left submerged in water for 1 hour. After 1 hour, the filter was withdrawn and water allowed to drip for 2 minutes. Excess water was removed using absorbent paper. The filter was weighted again. Water absorption (%) is calculated as 100×(mass wet filter−mass dry filter)/mass dry filter. The test results are summarized in
As can be seen, and as expected, the addition of siloxane based water-repellent additive significantly reduces water uptake (compare control 1 and control 2). The addition of phenalkamine even further reduces water uptake (compare B1 and control 1). The combination of silicon based water repellent and phenalkamine performs similarly to the sole phenalkamine additive (see B2).
The compositions Control 1 and B1 were subjected to dry and wet tensile strength tests as follows: suitable strips of impregnated and cured glass veils were placed onto a testometric machine (M350-10CT) and tested using a 50 kg load cell at an automated test speed of 10 mm/min controlled by winTest Analysis software. Various parameters such as maximum load at peak, stress at peak and modulus (stiffness) were evaluated by the software, and data presented as an average of 8 samples with standard deviation. The average maximum load at peak or stress at peak defined as the bond strength. For the wet test, the cured veil samples were placed in an autoclave (J8341, Vessel: PV02626 with associated safety valve, door interlock and integrated pipework) system. Samples were treated at 90% humidity and at a temperature ranging from 40° C. to 110° C. (full cycle), at a pressure of up to 2.62 bar, for 3 hours. The samples were dried completely in order to ensure no moisture remains onto the veils. The autoclave treated samples were tested for bond strength by means of testometric machine (M350-10CT) described here above, and the results were compared with those of untreated samples. The test results are summarized in
The same experiment was repeated with a binder composition comprising glucose and HMDA (hexamethylenediamine) in 85/15 ratio (B4) and a binder composition comprising glucose and HMDA (hexamethylenediamine) in 85/15 ratio plus 3 wt % phenalkamine (RAC950) added (B5) as a 10% aqueous dispersion. The results are shown in
Example 1 was repeated with a binder composition comprising glucose and ammonium sulphate in a ratio of 85:15 wt %, based on dry weight. A fraction of the obtained composition was retained as control. Another fraction was withdrawn and 1 wt % of polydimethylsiloxane based water repellent (Basildon Chemicals BC2631 which is a co-emulsion of blended reactive polydimethylsiloxanes for use on glass wool and mineral substrates) were added (based on dry weight) to form a second control. A further fraction of the initial binder composition was withdrawn and 0.5 wt % phenalkamine (RAC950 supplied by Royce International) were added as a 10% dispersion in water together with 0.5 wt % of the above polydimethylsiloxane.
The water pick-up results are shown in
Number | Date | Country | Kind |
---|---|---|---|
1610063 | Jun 2016 | GB | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2017/063147 | 5/31/2017 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2017/211642 | 12/14/2017 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1801052 | Meigs | Apr 1931 | A |
1801053 | Meigs | Apr 1931 | A |
1886353 | Novotny et al. | Nov 1932 | A |
1902948 | Castle | Mar 1933 | A |
1964263 | Krenke | Jun 1934 | A |
2198874 | Leighton | Apr 1940 | A |
2215825 | Wallace et al. | Sep 1940 | A |
2261295 | Schlack | Nov 1941 | A |
2362086 | Eastes et al. | Nov 1944 | A |
2371990 | Hanford | Mar 1945 | A |
2392105 | Sussman | Jan 1946 | A |
2442989 | Sussman | Jun 1948 | A |
2500665 | Courtright | Mar 1950 | A |
2518956 | Sussman | Aug 1950 | A |
2875073 | Gogek | Feb 1959 | A |
2894920 | Ramos | Jul 1959 | A |
2965504 | Gogek | Dec 1960 | A |
3038462 | Bohdan | Jun 1962 | A |
3138473 | Floyd et al. | Jun 1964 | A |
3222243 | Gaston et al. | Dec 1965 | A |
3231349 | Stalego | Jan 1966 | A |
3232821 | Banks et al. | Feb 1966 | A |
3297419 | Eyre, Jr. | Jan 1967 | A |
3513001 | Woodhead et al. | May 1970 | A |
3551365 | Matalon | Dec 1970 | A |
3784408 | Jaffe et al. | Jan 1974 | A |
3791807 | Etzel et al. | Feb 1974 | A |
3802897 | Bovier et al. | Apr 1974 | A |
3809664 | Burr et al. | May 1974 | A |
3826767 | Hoover et al. | Jul 1974 | A |
3856606 | Fan | Dec 1974 | A |
3867119 | Takeo et al. | Feb 1975 | A |
3907724 | Higginbottom | Sep 1975 | A |
3911048 | Nistri et al. | Oct 1975 | A |
3919134 | Higginbottom | Nov 1975 | A |
3922466 | Bell et al. | Nov 1975 | A |
3955031 | Jones et al. | May 1976 | A |
3956204 | Higginbottom | May 1976 | A |
3961081 | McKenzie | Jun 1976 | A |
3971807 | Brack | Jul 1976 | A |
4014726 | Fargo | Mar 1977 | A |
4028290 | Reid | Jun 1977 | A |
4048127 | Gibbons et al. | Sep 1977 | A |
4054713 | Sakaguchi et al. | Oct 1977 | A |
4085076 | Gibbons et al. | Apr 1978 | A |
4097427 | Aitken et al. | Jun 1978 | A |
4107379 | Stofko | Aug 1978 | A |
4109057 | Nakamura et al. | Aug 1978 | A |
4144027 | Habib | Mar 1979 | A |
4148765 | Nelson | Apr 1979 | A |
4183997 | Stofko | Jan 1980 | A |
4184986 | Krasnobajew et al. | Jan 1980 | A |
4186053 | Krasnobajew et al. | Jan 1980 | A |
4201247 | Shannon | May 1980 | A |
4201857 | Krasnobajew et al. | May 1980 | A |
4217414 | Walon | Aug 1980 | A |
4233432 | Curtis, Jr. | Nov 1980 | A |
4246367 | Curtis, Jr. | Jan 1981 | A |
4259190 | Fahey | Mar 1981 | A |
4265963 | Matalon | May 1981 | A |
4278573 | Tessler | Jul 1981 | A |
4296173 | Fahey | Oct 1981 | A |
4301310 | Wagner | Nov 1981 | A |
4310585 | Shannon | Jan 1982 | A |
4322523 | Wagner | Mar 1982 | A |
4330443 | Rankin | May 1982 | A |
4333484 | Keritsis | Jun 1982 | A |
4357194 | Stofko | Nov 1982 | A |
4361588 | Herz | Nov 1982 | A |
4379101 | Smith | Apr 1983 | A |
4393019 | Geimer | Jul 1983 | A |
4396430 | Matalon | Aug 1983 | A |
4400496 | Butler et al. | Aug 1983 | A |
4464523 | Neigel et al. | Aug 1984 | A |
4506684 | Keritsis | Mar 1985 | A |
4520143 | Jellinek | May 1985 | A |
4524164 | Viswanathan et al. | Jun 1985 | A |
4631226 | Jellinek | Dec 1986 | A |
4654259 | Stofko | Mar 1987 | A |
4668716 | Pepe et al. | May 1987 | A |
4692478 | Viswanathan et al. | Sep 1987 | A |
4714727 | Hume, III | Dec 1987 | A |
4720295 | Bronshtein | Jan 1988 | A |
4734996 | Kim et al. | Apr 1988 | A |
4754056 | Ansel et al. | Jun 1988 | A |
4761184 | Markessini | Aug 1988 | A |
4780339 | Lacourse et al. | Oct 1988 | A |
4828643 | Newman et al. | May 1989 | A |
4845162 | Schmitt et al. | Jul 1989 | A |
4906237 | Johansson et al. | Mar 1990 | A |
4912147 | Pfoehler et al. | Mar 1990 | A |
4918861 | Carpenter et al. | Apr 1990 | A |
4923980 | Blomberg | May 1990 | A |
4950444 | Deboufie et al. | Aug 1990 | A |
4988780 | Das et al. | Jan 1991 | A |
4992519 | Mukherjee | Feb 1991 | A |
5001202 | Denis et al. | Mar 1991 | A |
5013405 | Izard | May 1991 | A |
5032431 | Conner et al. | Jul 1991 | A |
5037930 | Shih | Aug 1991 | A |
5041595 | Yang et al. | Aug 1991 | A |
5089342 | Dhein et al. | Feb 1992 | A |
5095054 | Lay et al. | Mar 1992 | A |
5106615 | Dikstein | Apr 1992 | A |
5114004 | Isono et al. | May 1992 | A |
5123949 | Thiessen | Jun 1992 | A |
5124369 | Vandichel et al. | Jun 1992 | A |
5128407 | Layton et al. | Jul 1992 | A |
5143582 | Arkens et al. | Sep 1992 | A |
5151465 | Le-Khac | Sep 1992 | A |
5167738 | Bichot et al. | Dec 1992 | A |
5198492 | Stack | Mar 1993 | A |
5217741 | Kawachi et al. | Jun 1993 | A |
5218048 | Abe et al. | Jun 1993 | A |
5240498 | Matalon et al. | Aug 1993 | A |
5278222 | Stack | Jan 1994 | A |
5300144 | Adams | Apr 1994 | A |
5300192 | Hansen et al. | Apr 1994 | A |
5308896 | Hansen et al. | May 1994 | A |
5318990 | Strauss | Jun 1994 | A |
5336753 | Jung et al. | Aug 1994 | A |
5336755 | Pape | Aug 1994 | A |
5336766 | Koga et al. | Aug 1994 | A |
5340868 | Strauss et al. | Aug 1994 | A |
5352480 | Hansen et al. | Oct 1994 | A |
5367849 | Bullock | Nov 1994 | A |
5371194 | Ferretti | Dec 1994 | A |
5387665 | Misawa et al. | Feb 1995 | A |
5389716 | Graves | Feb 1995 | A |
5393849 | Srinivasan et al. | Feb 1995 | A |
5416139 | Zeiszler | May 1995 | A |
5421838 | Gosset et al. | Jun 1995 | A |
5424418 | Duflot | Jun 1995 | A |
5434233 | Kiely et al. | Jul 1995 | A |
5447977 | Hansen et al. | Sep 1995 | A |
5470843 | Stahl et al. | Nov 1995 | A |
5480973 | Goodlad et al. | Jan 1996 | A |
5492756 | Seale et al. | Feb 1996 | A |
5498662 | Tanaka et al. | Mar 1996 | A |
5503920 | Alkire et al. | Apr 1996 | A |
5534612 | Taylor et al. | Jul 1996 | A |
5536766 | Seyffer et al. | Jul 1996 | A |
5538783 | Hansen et al. | Jul 1996 | A |
5543215 | Hansen et al. | Aug 1996 | A |
5545279 | Hall et al. | Aug 1996 | A |
5547541 | Hansen et al. | Aug 1996 | A |
5547745 | Hansen et al. | Aug 1996 | A |
5550189 | Qin et al. | Aug 1996 | A |
5554730 | Woiszwillo et al. | Sep 1996 | A |
5562740 | Cook et al. | Oct 1996 | A |
5571618 | Hansen et al. | Nov 1996 | A |
5578678 | Hartmann et al. | Nov 1996 | A |
5580856 | Prestrelski et al. | Dec 1996 | A |
5582682 | Ferretti | Dec 1996 | A |
5583193 | Aravindakshan et al. | Dec 1996 | A |
5589256 | Hansen et al. | Dec 1996 | A |
5589536 | Golino et al. | Dec 1996 | A |
5607759 | Hansen et al. | Mar 1997 | A |
5608011 | Eck et al. | Mar 1997 | A |
5609727 | Hansen et al. | Mar 1997 | A |
5614570 | Hansen et al. | Mar 1997 | A |
5620940 | Birbara et al. | Apr 1997 | A |
5621026 | Tanaka et al. | Apr 1997 | A |
5633298 | Arfaei et al. | May 1997 | A |
5641561 | Hansen et al. | Jun 1997 | A |
5643978 | Darwin et al. | Jul 1997 | A |
5645756 | Dubin et al. | Jul 1997 | A |
5660904 | Andersen et al. | Aug 1997 | A |
5661213 | Arkens et al. | Aug 1997 | A |
5670585 | Taylor et al. | Sep 1997 | A |
5672418 | Hansen et al. | Sep 1997 | A |
5672659 | Shalaby et al. | Sep 1997 | A |
5690715 | Schiwek | Nov 1997 | A |
5691060 | Levy | Nov 1997 | A |
5693411 | Hansen et al. | Dec 1997 | A |
5719092 | Arrington | Feb 1998 | A |
5719228 | Taylor et al. | Feb 1998 | A |
5733624 | Syme et al. | Mar 1998 | A |
5756580 | Natori et al. | May 1998 | A |
5763524 | Arkens et al. | Jun 1998 | A |
5788243 | Harshaw et al. | Aug 1998 | A |
5788423 | Perkins | Aug 1998 | A |
5807364 | Hansen | Sep 1998 | A |
5855987 | Margel et al. | Jan 1999 | A |
5863985 | Shalaby et al. | Jan 1999 | A |
5885337 | Nohr et al. | Mar 1999 | A |
5895804 | Lee et al. | Apr 1999 | A |
5905115 | Luitjes et al. | May 1999 | A |
5916503 | Rettenbacher | Jun 1999 | A |
5919528 | Huijs et al. | Jul 1999 | A |
5919831 | Philipp | Jul 1999 | A |
5922403 | Tecle | Jul 1999 | A |
5925722 | Exner et al. | Jul 1999 | A |
5929184 | Holmes-Farley et al. | Jul 1999 | A |
5929196 | Kissel et al. | Jul 1999 | A |
5932344 | Ikemoto et al. | Aug 1999 | A |
5932665 | Deporter et al. | Aug 1999 | A |
5932689 | Arkens et al. | Aug 1999 | A |
5942123 | McArdle | Aug 1999 | A |
5954869 | Elfersy et al. | Sep 1999 | A |
5977224 | Cheung et al. | Nov 1999 | A |
5977232 | Arkens et al. | Nov 1999 | A |
5981719 | Woiszwillo et al. | Nov 1999 | A |
5983586 | Berdan, II et al. | Nov 1999 | A |
5990216 | Cai et al. | Nov 1999 | A |
5993709 | Bonomo et al. | Nov 1999 | A |
6022615 | Rettenbacher | Feb 2000 | A |
6067821 | Jackson et al. | May 2000 | A |
6071549 | Hansen | Jun 2000 | A |
6071994 | Hummerich et al. | Jun 2000 | A |
6072086 | James et al. | Jun 2000 | A |
6077883 | Taylor et al. | Jun 2000 | A |
6090925 | Woiszwillo et al. | Jul 2000 | A |
6114033 | Ikemoto et al. | Sep 2000 | A |
6114464 | Reck et al. | Sep 2000 | A |
6133347 | Vickers, Jr. et al. | Oct 2000 | A |
6136916 | Arkens et al. | Oct 2000 | A |
6139619 | Zaretskiy et al. | Oct 2000 | A |
6143243 | Gershun et al. | Nov 2000 | A |
6171444 | Nigam | Jan 2001 | B1 |
6171654 | Salsman et al. | Jan 2001 | B1 |
6180037 | Andersen et al. | Jan 2001 | B1 |
6194512 | Chen et al. | Feb 2001 | B1 |
6210472 | Kwan et al. | Apr 2001 | B1 |
6221958 | Shalaby et al. | Apr 2001 | B1 |
6221973 | Arkens et al. | Apr 2001 | B1 |
6231721 | Quick et al. | May 2001 | B1 |
6274661 | Chen et al. | Aug 2001 | B1 |
6281298 | Papsin, Jr. | Aug 2001 | B1 |
6299677 | Johnson et al. | Oct 2001 | B1 |
6299936 | Reck et al. | Oct 2001 | B1 |
6307732 | Tsubaki et al. | Oct 2001 | B1 |
6310227 | Sarama et al. | Oct 2001 | B1 |
6313102 | Colaco et al. | Nov 2001 | B1 |
6319683 | James et al. | Nov 2001 | B1 |
6331350 | Taylor et al. | Dec 2001 | B1 |
6331513 | Zaid et al. | Dec 2001 | B1 |
6340411 | Hansen et al. | Jan 2002 | B1 |
6348530 | Reck et al. | Feb 2002 | B1 |
6365079 | Winkler et al. | Apr 2002 | B1 |
6372077 | Tecle | Apr 2002 | B1 |
6379739 | Formanek et al. | Apr 2002 | B1 |
6379814 | Dupre et al. | Apr 2002 | B1 |
6395856 | Petty et al. | May 2002 | B1 |
6403665 | Sieker et al. | Jun 2002 | B1 |
6407225 | Mang et al. | Jun 2002 | B1 |
6410036 | De Rosa et al. | Jun 2002 | B1 |
6440204 | Rogols et al. | Aug 2002 | B1 |
6441122 | DeMott et al. | Aug 2002 | B1 |
6461553 | Hansen et al. | Oct 2002 | B1 |
6468442 | Bytnar | Oct 2002 | B2 |
6468730 | Fujiwara et al. | Oct 2002 | B2 |
6469120 | Elfersy et al. | Oct 2002 | B1 |
6475552 | Shah et al. | Nov 2002 | B1 |
6482875 | Lorenz et al. | Nov 2002 | B2 |
6495656 | Haile et al. | Dec 2002 | B1 |
6521339 | Hansen et al. | Feb 2003 | B1 |
6525009 | Sachdev et al. | Feb 2003 | B2 |
6538057 | Wildburg et al. | Mar 2003 | B1 |
6547867 | Rogols et al. | Apr 2003 | B2 |
6555616 | Helbing et al. | Apr 2003 | B1 |
6559302 | Shah et al. | May 2003 | B1 |
6562267 | Hansen et al. | May 2003 | B1 |
6596103 | Hansen et al. | Jul 2003 | B1 |
6613378 | Erhan et al. | Sep 2003 | B1 |
6638882 | Helbing et al. | Oct 2003 | B1 |
6638884 | Quick et al. | Oct 2003 | B2 |
6699945 | Chen et al. | Mar 2004 | B1 |
6706853 | Stanssens et al. | Mar 2004 | B1 |
6719862 | Quick et al. | Apr 2004 | B2 |
6730730 | Hansen et al. | May 2004 | B1 |
6753361 | Kroner et al. | Jun 2004 | B2 |
6818694 | Hindi et al. | Nov 2004 | B2 |
6821547 | Shah et al. | Nov 2004 | B2 |
6852247 | Bytnar | Feb 2005 | B2 |
6858074 | Anderson et al. | Feb 2005 | B2 |
6861495 | Barsotti et al. | Mar 2005 | B2 |
6864044 | Ishikawa et al. | Mar 2005 | B2 |
6878800 | Husemoen et al. | Apr 2005 | B2 |
6884849 | Chen et al. | Apr 2005 | B2 |
6955844 | Tagge et al. | Oct 2005 | B2 |
6962714 | Hei et al. | Nov 2005 | B2 |
6989171 | Portman | Jan 2006 | B2 |
6992203 | Trusovs | Jan 2006 | B2 |
7018490 | Hansen et al. | Mar 2006 | B2 |
7029717 | Ojima et al. | Apr 2006 | B1 |
7067579 | Taylor et al. | Jun 2006 | B2 |
7083831 | Koch et al. | Aug 2006 | B1 |
7090745 | Beckman et al. | Aug 2006 | B2 |
7141626 | Rodrigues et al. | Nov 2006 | B2 |
7144474 | Hansen et al. | Dec 2006 | B1 |
7195792 | Boston et al. | Mar 2007 | B2 |
7201778 | Smith et al. | Apr 2007 | B2 |
7201825 | Dezutter et al. | Apr 2007 | B2 |
7202326 | Kuroda et al. | Apr 2007 | B2 |
7241487 | Taylor et al. | Jul 2007 | B2 |
7458235 | Beaufils et al. | Dec 2008 | B2 |
7514027 | Horres et al. | Apr 2009 | B2 |
7655711 | Swift et al. | Feb 2010 | B2 |
7772347 | Swift et al. | Aug 2010 | B2 |
7795354 | Srinivasan et al. | Sep 2010 | B2 |
7803879 | Srinivasan et al. | Sep 2010 | B2 |
7807771 | Swift et al. | Oct 2010 | B2 |
7842382 | Helbing | Nov 2010 | B2 |
7854980 | Jackson et al. | Dec 2010 | B2 |
7883693 | Sehl et al. | Feb 2011 | B2 |
7888445 | Swift et al. | Feb 2011 | B2 |
7947765 | Swift et al. | May 2011 | B2 |
8114210 | Hampson et al. | Feb 2012 | B2 |
8182648 | Swift et al. | May 2012 | B2 |
8211923 | Wagner et al. | Jul 2012 | B2 |
8372900 | Shooshtari et al. | Feb 2013 | B2 |
8377564 | Shooshtari et al. | Feb 2013 | B2 |
8501838 | Jackson et al. | Aug 2013 | B2 |
8680224 | Zhang et al. | Mar 2014 | B2 |
8691934 | Helbing et al. | Apr 2014 | B2 |
8900495 | Pacorel et al. | Dec 2014 | B2 |
20010017427 | Rosthauser et al. | Aug 2001 | A1 |
20010046824 | Nigam | Nov 2001 | A1 |
20020000100 | Burg et al. | Jan 2002 | A1 |
20020025435 | Hansen et al. | Feb 2002 | A1 |
20020026025 | Kuo et al. | Feb 2002 | A1 |
20020028857 | Holy | Mar 2002 | A1 |
20020032253 | Lorenz et al. | Mar 2002 | A1 |
20020042473 | Trollsas et al. | Apr 2002 | A1 |
20020091185 | Taylor et al. | Jul 2002 | A1 |
20020096278 | Foster et al. | Jul 2002 | A1 |
20020123598 | Sieker et al. | Sep 2002 | A1 |
20020130439 | Kroner et al. | Sep 2002 | A1 |
20020161108 | Schultz et al. | Oct 2002 | A1 |
20020197352 | Portman | Dec 2002 | A1 |
20030005857 | Minami et al. | Jan 2003 | A1 |
20030040239 | Toas et al. | Feb 2003 | A1 |
20030044513 | Shah et al. | Mar 2003 | A1 |
20030066523 | Lewis et al. | Apr 2003 | A1 |
20030071879 | Swenson | Apr 2003 | A1 |
20030116294 | Kehrer et al. | Jun 2003 | A1 |
20030134945 | Capps | Jul 2003 | A1 |
20030148084 | Trocino | Aug 2003 | A1 |
20030153690 | Husemoen et al. | Aug 2003 | A1 |
20030185991 | Wigger et al. | Oct 2003 | A1 |
20030203117 | Bartkowiak et al. | Oct 2003 | A1 |
20040002567 | Chen et al. | Jan 2004 | A1 |
20040019168 | Soerens et al. | Jan 2004 | A1 |
20040024170 | Husemoen et al. | Feb 2004 | A1 |
20040033269 | Hei et al. | Feb 2004 | A1 |
20040033747 | Miller et al. | Feb 2004 | A1 |
20040034154 | Tutin et al. | Feb 2004 | A1 |
20040038017 | Tutin et al. | Feb 2004 | A1 |
20040048531 | Belmares et al. | Mar 2004 | A1 |
20040077055 | Fosdick et al. | Apr 2004 | A1 |
20040079499 | Dezutter et al. | Apr 2004 | A1 |
20040087024 | Bellocq et al. | May 2004 | A1 |
20040087719 | Rautschek et al. | May 2004 | A1 |
20040122166 | O'Brien-Bernini et al. | Jun 2004 | A1 |
20040131874 | Tutin et al. | Jul 2004 | A1 |
20040144706 | Beaufils et al. | Jul 2004 | A1 |
20040152824 | Dobrowolski | Aug 2004 | A1 |
20040161993 | Tripp et al. | Aug 2004 | A1 |
20040209851 | Nelson et al. | Oct 2004 | A1 |
20040213930 | Halabisky | Oct 2004 | A1 |
20040220368 | Li et al. | Nov 2004 | A1 |
20040249066 | Heinzman et al. | Dec 2004 | A1 |
20040254285 | Rodrigues et al. | Dec 2004 | A1 |
20040260082 | Van Der Wilden et al. | Dec 2004 | A1 |
20050001198 | Bytnar | Jan 2005 | A1 |
20050017394 | Hochsmann | Jan 2005 | A1 |
20050027283 | Richard et al. | Feb 2005 | A1 |
20050033037 | Trusovs | Feb 2005 | A1 |
20050048212 | Clamen et al. | Mar 2005 | A1 |
20050059770 | Srinivasan et al. | Mar 2005 | A1 |
20050171085 | Pinto et al. | Aug 2005 | A1 |
20050196421 | Hunter et al. | Sep 2005 | A1 |
20050202224 | Helbing | Sep 2005 | A1 |
20050208852 | Weber | Sep 2005 | A1 |
20050215153 | Cossement et al. | Sep 2005 | A1 |
20050245669 | Clungeon et al. | Nov 2005 | A1 |
20050275133 | Cabell et al. | Dec 2005 | A1 |
20050288479 | Kuroda et al. | Dec 2005 | A1 |
20060005580 | Espiard et al. | Jan 2006 | A1 |
20060009569 | Charbonneau et al. | Jan 2006 | A1 |
20060044302 | Chen | Mar 2006 | A1 |
20060099870 | Garcia et al. | May 2006 | A1 |
20060111480 | Hansen et al. | May 2006 | A1 |
20060124538 | Morcrette et al. | Jun 2006 | A1 |
20060135433 | Murray et al. | Jun 2006 | A1 |
20060141177 | Ligtenberg et al. | Jun 2006 | A1 |
20060179892 | Horres et al. | Aug 2006 | A1 |
20060188465 | Perrier et al. | Aug 2006 | A1 |
20060198954 | Frechem et al. | Sep 2006 | A1 |
20060231487 | Bartley et al. | Oct 2006 | A1 |
20060252855 | Pisanova et al. | Nov 2006 | A1 |
20060281622 | Maricourt et al. | Dec 2006 | A1 |
20070006390 | Clamen et al. | Jan 2007 | A1 |
20070009582 | Madsen et al. | Jan 2007 | A1 |
20070027281 | Michl et al. | Feb 2007 | A1 |
20070039520 | Crews et al. | Feb 2007 | A1 |
20070082983 | Crews et al. | Apr 2007 | A1 |
20070123679 | Swift et al. | May 2007 | A1 |
20070123680 | Swift et al. | May 2007 | A1 |
20070129522 | Burckhardt et al. | Jun 2007 | A1 |
20070142596 | Swift et al. | Jun 2007 | A1 |
20070158022 | Heep et al. | Jul 2007 | A1 |
20070184740 | Keller et al. | Aug 2007 | A1 |
20070191574 | Miller et al. | Aug 2007 | A1 |
20070270070 | Othman | Nov 2007 | A1 |
20070287018 | Tutin et al. | Dec 2007 | A1 |
20070292618 | Srinivasan et al. | Dec 2007 | A1 |
20070292619 | Srinivasan et al. | Dec 2007 | A1 |
20070298274 | Eriksson et al. | Dec 2007 | A1 |
20080009209 | Clamen et al. | Jan 2008 | A1 |
20080009616 | Frank et al. | Jan 2008 | A1 |
20080051539 | Kelly | Feb 2008 | A1 |
20080060551 | Crews et al. | Mar 2008 | A1 |
20080081138 | Moore et al. | Apr 2008 | A1 |
20080108741 | Van Herwijnen et al. | May 2008 | A1 |
20080160260 | Wada et al. | Jul 2008 | A1 |
20080160302 | Asrar et al. | Jul 2008 | A1 |
20080194738 | Crews et al. | Aug 2008 | A1 |
20090169867 | Kelly | Jul 2009 | A1 |
20090170978 | Kelly | Jul 2009 | A1 |
20090227732 | Glockner et al. | Sep 2009 | A1 |
20090301972 | Hines et al. | Dec 2009 | A1 |
20090304919 | Huenig et al. | Dec 2009 | A1 |
20090306255 | Patel et al. | Dec 2009 | A1 |
20090324915 | Swift et al. | Dec 2009 | A1 |
20100029160 | Srinivasan et al. | Feb 2010 | A1 |
20100058661 | Jackson et al. | Mar 2010 | A1 |
20100080976 | Jackson et al. | Apr 2010 | A1 |
20100084598 | Jackson et al. | Apr 2010 | A1 |
20100086726 | Jackson et al. | Apr 2010 | A1 |
20100087571 | Jackson et al. | Apr 2010 | A1 |
20100098947 | Inoue et al. | Apr 2010 | A1 |
20100117023 | Dopico et al. | May 2010 | A1 |
20100129640 | Kelly | May 2010 | A1 |
20100130649 | Swift et al. | May 2010 | A1 |
20100175826 | Huenig et al. | Jul 2010 | A1 |
20100210595 | Wagner et al. | Aug 2010 | A1 |
20100222463 | Brady et al. | Sep 2010 | A1 |
20100222566 | Fosdick et al. | Sep 2010 | A1 |
20100282996 | Jaffrennou et al. | Nov 2010 | A1 |
20100301256 | Hampson et al. | Dec 2010 | A1 |
20100320113 | Swift | Dec 2010 | A1 |
20110021672 | Crews et al. | Jan 2011 | A1 |
20110039111 | Shooshtari | Feb 2011 | A1 |
20110040010 | Shooshtari | Feb 2011 | A1 |
20110042303 | Shooshtari et al. | Feb 2011 | A1 |
20110045966 | Shooshtari et al. | Feb 2011 | A1 |
20110089074 | Jackson et al. | Apr 2011 | A1 |
20110135937 | Swift et al. | Jun 2011 | A1 |
20110190425 | Swift | Aug 2011 | A1 |
20110220835 | Swift et al. | Sep 2011 | A1 |
20110256790 | Toas et al. | Oct 2011 | A1 |
20110260094 | Hampson et al. | Oct 2011 | A1 |
20110262648 | Lee et al. | Oct 2011 | A1 |
20110263757 | Rand et al. | Oct 2011 | A1 |
20110306726 | Bailey et al. | Dec 2011 | A1 |
20120037036 | Veit et al. | Feb 2012 | A1 |
20120133073 | Pacorel et al. | May 2012 | A1 |
20120156954 | Eckert et al. | Jun 2012 | A1 |
20130029150 | Appley et al. | Jan 2013 | A1 |
20130032749 | Jaffrennou et al. | Feb 2013 | A1 |
20130047888 | Mueller et al. | Feb 2013 | A1 |
20130059075 | Appley et al. | Mar 2013 | A1 |
20130082205 | Mueller et al. | Apr 2013 | A1 |
20130174758 | Mueller | Jul 2013 | A1 |
20130234362 | Swift et al. | Sep 2013 | A1 |
20130236650 | Swift et al. | Sep 2013 | A1 |
20130237113 | Swift et al. | Sep 2013 | A1 |
20130244524 | Swift et al. | Sep 2013 | A1 |
20140091247 | Jackson et al. | Apr 2014 | A1 |
20140134909 | Guo et al. | May 2014 | A1 |
20140357787 | Jobber et al. | Dec 2014 | A1 |
Number | Date | Country |
---|---|---|
8538765 | Aug 1985 | AU |
9640921 | Jul 1997 | AU |
1090026 | Nov 1980 | CA |
2037214 | Sep 1991 | CA |
2232334 | Nov 1998 | CA |
2458333 | Dec 1999 | CA |
2278946 | Jan 2000 | CA |
2470783 | Dec 2004 | CA |
1251738 | May 2000 | CN |
1905054 | Aug 1969 | DE |
4142261 | Jun 1993 | DE |
4233622 | Apr 1994 | DE |
4308089 | Sep 1994 | DE |
102004033561 | Sep 2005 | DE |
102005023431 | Nov 2006 | DE |
0044614 | Jan 1982 | EP |
0099801 | Feb 1984 | EP |
354023 | Feb 1990 | EP |
0461995 | Dec 1991 | EP |
0524518 | Jan 1993 | EP |
0547819 | Jun 1993 | EP |
0583086 | Feb 1994 | EP |
0714754 | Jun 1996 | EP |
796681 | Sep 1997 | EP |
0826710 | Mar 1998 | EP |
856494 | Aug 1998 | EP |
0873976 | Oct 1998 | EP |
878135 | Nov 1998 | EP |
0882756 | Dec 1998 | EP |
0911361 | Apr 1999 | EP |
915811 | May 1999 | EP |
936060 | Aug 1999 | EP |
976866 | Feb 2000 | EP |
0990729 | Apr 2000 | EP |
1038433 | Sep 2000 | EP |
1193288 | Apr 2002 | EP |
1084167 | Sep 2002 | EP |
1268702 | Jan 2003 | EP |
1382642 | Jan 2004 | EP |
1486547 | Dec 2004 | EP |
1522642 | Apr 2005 | EP |
1698598 | Sep 2006 | EP |
1767566 | Apr 2007 | EP |
2223940 | Sep 2010 | EP |
2223941 | Sep 2010 | EP |
2253663 | Nov 2010 | EP |
2614388 | Oct 1988 | FR |
770561 | Mar 1957 | GB |
809675 | Mar 1959 | GB |
926749 | May 1963 | GB |
1391172 | Apr 1975 | GB |
1469331 | Apr 1977 | GB |
1512066 | May 1978 | GB |
1525541 | Sep 1978 | GB |
2047258 | Nov 1980 | GB |
2078805 | Jan 1982 | GB |
2173523 | Oct 1986 | GB |
2251438 | Jul 1992 | GB |
53113784 | Oct 1978 | JP |
57101100 | Jun 1982 | JP |
5811193 | Jan 1983 | JP |
61195647 | Aug 1986 | JP |
3-173680 | Jul 1991 | JP |
05186635 | Jul 1993 | JP |
7-034023 | Feb 1995 | JP |
09157627 | Jun 1997 | JP |
10234314 | Sep 1998 | JP |
11035491 | Feb 1999 | JP |
11181690 | Jul 1999 | JP |
2000327841 | Nov 2000 | JP |
2002293576 | Sep 2002 | JP |
2003147276 | May 2003 | JP |
2003238921 | Aug 2003 | JP |
2004060058 | Feb 2004 | JP |
2005306919 | Nov 2005 | JP |
549563 | Jan 2008 | NZ |
1765996 | Aug 1995 | RU |
374400 | Mar 1973 | SU |
1990007541 | Jul 1990 | WO |
1992012198 | Jul 1992 | WO |
1995034517 | Dec 1995 | WO |
1997049646 | Dec 1997 | WO |
1999036368 | Jul 1999 | WO |
199947765 | Sep 1999 | WO |
199960042 | Nov 1999 | WO |
199960043 | Nov 1999 | WO |
200058085 | Oct 2000 | WO |
2001014491 | Mar 2001 | WO |
2001059026 | Aug 2001 | WO |
200200429 | Jan 2002 | WO |
200206178 | Jan 2002 | WO |
2003029496 | Apr 2003 | WO |
2003071879 | Sep 2003 | WO |
2003106561 | Dec 2003 | WO |
2004007615 | Jan 2004 | WO |
2004076734 | Sep 2004 | WO |
2005087837 | Sep 2005 | WO |
2006044302 | Apr 2006 | WO |
2006136614 | Dec 2006 | WO |
2007014236 | Feb 2007 | WO |
2007024020 | Mar 2007 | WO |
2007050964 | May 2007 | WO |
2007112335 | Oct 2007 | WO |
2008089847 | Jul 2008 | WO |
2008089851 | Jul 2008 | WO |
2008141201 | Nov 2008 | WO |
2009019235 | Feb 2009 | WO |
2009129084 | Oct 2009 | WO |
2010027937 | Mar 2010 | WO |
2010139899 | Dec 2010 | WO |
2011019590 | Feb 2011 | WO |
2011019593 | Feb 2011 | WO |
2011019597 | Feb 2011 | WO |
2011019598 | Feb 2011 | WO |
2011022224 | Feb 2011 | WO |
2011022226 | Feb 2011 | WO |
2011022227 | Feb 2011 | WO |
2011091585 | Aug 2011 | WO |
2011138458 | Nov 2011 | WO |
2011138458 | Nov 2011 | WO |
2011138459 | Nov 2011 | WO |
2012152731 | Nov 2012 | WO |
2013030390 | Mar 2013 | WO |
2013150123 | Oct 2013 | WO |
2013159279 | Oct 2013 | WO |
Entry |
---|
International Search Report and Written Opinion for PCT/US2008/059730, completed Sep. 22, 2008. |
International Search Report and Written Opinion for PCT/US2008/069046, completed Sep. 25, 2008. |
International Search Report and Written Opinion for PCT/EP2011/059317, completed Jul. 15, 2011. |
International Search Report for PCT/EP2008/060185, completed Oct. 23, 2008. |
International Search Report for PCT/EP2011/057363, completed Sep. 5, 2011. |
Ames, J.M., “The Maillard Browning Reaction—an Update, ”Chemistry & Industry, No. 17, 1988, 4 pages. |
“Gamma-aminopropyltrimethoxysilane,” Hawley's Condensed Chemical Dictionary, 14th Edition, John Wiley & Sons, Inc., 2002, 1 page. |
Hodge, J.E., Chemistry of Browning Reactions in Model Systems, 1953, J. Agric. Food Chem., vol. 1, No. 15, pp. 928-943. |
Agyei-Aye et al., “The Role of Anion in the Reaction of Reducing Sugars with Ammonium Salts,” Carbohydrate Research 2002, 337: 2273-2277. |
Laroque et al., “Kinetic study on the Maillard reaction. Consideration of sugar reactivity,” Food Chemistry 2008, 111: 1032-1042. |
Bjorksten et al., “Polyester Resin—Glass Fiber Laminates,” Industrial and Engineering Chemistry (1954). |
Dow Corning, “A Guide to Silane Solutions,” 2005. |
Knauf Data Sheet, 2006. |
Molasses Corporation, United States Sugar Corporation, http://www.suga-lik.com/molasses/composition.html (Sep. 29, 2003). |
Clamen, Guy, “Acrylic Thermosets: A Safe Alternative to Formaldehyde Resins,” Nonwovens World, Apr.-May 2004, pp. 96-102. |
Opposition to AU 2006272595, Amended Statement of Grounds and Particulars, issued from Australian Patent Office, Jul. 6, 2012, 22 pages. |
Decision re Opposition to AU 2006272595, issued from Australian Patent Office, Aug. 14, 2015, 25 pages. |
Opposition to EP 1732968, Notice of Opposition: Prior Art, Scope of the Patent, Reasons for the Opposition, issued from European Patent Office, Mar. 8, 2012, 18 pages. |
Decision re Opposition to EP 1732968, issued from the European Patent Office, Nov. 14, 2014, 5 pages. |
Opposition to EA 019802, submitted to Eurasian Patent Office on Dec. 26, 2014, 36 pages. |
Decision re Opposition to EA 019802, issued by Eurasian Patent Office on Aug. 18, 2015, 15 pages. |
Owens Corning Retiree Update: What Goes Around, Comes Around: A tale of Natural Binders, revised Mar. 20, 2013 p. 4. |
A.P. Bryant, “The Terminology of Sugars,” Industrial and Engineering Chemistry, vol. 26, No. 2, p. 231, Feb. 1934. |
Food Flavor Chemistry, p. 162, Mar. 21, 2009 (English Abstract). |
Viswanathan, T., “Chapter 28: Thermosetting Adhesive Resins from Whey and Whey Byproducts,” in Adhesives from Renewable Resources, ACS Symposium Series, Hemingway, R.W., et al. (Eds.), American Chemical Society, Washington, DC (1989). |
Viswanathan, T., and Richardson, T., “Thermosetting Adhesive Resins from Whey and Whey Byproducts,” Ind. Eng. Chem. Prod. Res. Dev. 23:644-47, American Chemical Society, United States (1984). |
Residential Energy Conservation: vol. 1, Congress of the U.S., Office of Technology Assessment (Ed.), 357 pages (Jan. 1, 1979). |
Office action for co-pending U.S. Appl. No. 12/524,502 (9 pages)—dated Sep. 21, 2012. |
Office action for co-pending U.S. Appl. No. 12/524,502 (9 pages)—dated Apr. 4, 2013. |
Office action for co-pending U.S. Appl. No. 12/524,512 (7 pages)—dated Aug. 6, 2012. |
Office action for co-pending U.S. Appl. No. 12/524,512 (9 pages)—dated Apr. 1, 2013. |
Office action for co-pending U.S. Appl. No. 12/524,512 (14 pages)—dated Nov. 12, 2014. |
Office action for co-pending U.S. Appl. No. 12/524,512 (9 pages)—dated Jul. 10, 2015. |
Office action for co-pending U.S. Appl. No. 12/524,512 (10 pages)—dated Mar. 23, 2016. |
Office action for co-pending U.S. Appl. No. 12/524,512 (13 pages)—dated Oct. 5, 2016. |
Office action for co-pending U.S. Appl. No. 12/524,512 (13 pages)—dated Apr. 6, 2018. |
Office action for co-pending US Appl. No. 12/524,512 (15 pages)—dated Jan. 17, 2019. |
Office action for co-pending U.S. Appl. No. 12/524,469 (7 pages)—dated Jun. 7, 2012. |
Office action for co-pending U.S. Appl. No. 12/524,469 (8 pages)—dated Jan. 29, 2013. |
Office action for co-pending U.S. Appl. No. 12/524,469 (7 pages)—dated Aug. 20, 2013. |
Office action for co-pending U.S. Appl. No. 12/524,469 (9 pages)—dated Jun. 9, 2014. |
Office action for co-pending U.S. Appl. No. 12/524,469 (9 pages)—dated Oct. 17, 2014. |
Office action for co-pending U.S. Appl. No. 12/524,469 (9 pages)—dated Jul. 23, 2015. |
Office action for co-pending U.S. Appl. No. 12/524,539 (13 pages)—dated Jun. 21, 2012. |
Office action for co-pending U.S. Appl. No. 12/524,539 (13 pages)—dated Jun. 6, 2013. |
Office action for co-pending U.S. Appl. No. 12/524,539 (12 pages)—dated Dec. 17, 2014. |
Office action for co-pending U.S. Appl. No. 12/524,539 (7 pages)—dated Jul. 15, 2015. |
Office action for co-pending U.S. Appl. No. 12/524,539 (7 pages)—dated Mar. 23, 2016. |
Office action for co-pending U.S. Appl. No. 12/524,539 (7 pages)—dated Dec. 29, 2016. |
Office action for co-pending U.S. Appl. No. 12/524,522 (4 pages)—dated Oct. 11, 2011. |
Office action for co-pending U.S. Appl. No. 12/667,718 (5 pages)—dated Sep. 3, 2013. |
Office action for co-pending U.S. Appl. No. 12/667,718 (6 pages)—dated Sep. 9, 2014. |
Office action for co-pending U.S. Appl. No. 12/671,922 (10 pages)—dated Oct. 7, 2011. |
Office action for co-pending U.S. Appl. No. 12/671,922 (10 pages)—dated May 10, 2012. |
Office action for co-pending U.S. Appl. No. 12/671,922 (9 pages)—dated Sep. 23, 2014. |
Office action for co-pending U.S. Appl. No. 12/671,922 (5 pages)—dated Apr. 4, 2016. |
Office action for co-pending U.S. Appl. No. 13/388,408 (5 pages)—dated Aug. 15, 2013. |
Office action for co-pending U.S. Appl. No. 13/371,829 (9 pages)—dated Dec. 20, 2012. |
Office action for co-pending U.S. Appl. No. 13/371,829 (6 pages)—dated Jul. 12, 2013. |
Office action for co-pending U.S. Appl. No. 13/371,829 (6 pages)—dated Aug. 12, 2014. |
Office action for co-pending U.S. Appl. No. 13/637,794 (8 pages)—dated Aug. 12, 2013. |
Office action for co-pending U.S. Appl. No. 13/637,794 (9 pages)—dated Mar. 26, 2014. |
Office action for co-pending U.S. Appl. No. 13/696,439 (11 pages)—dated Jan. 8, 2014. |
Office action for co-pending U.S. Appl. No. 13/696,452 (7 pages)—dated Jan. 13, 2015. |
Office action for co-pending U.S. Appl. No. 13/696,452 (9 pages)—dated Oct. 27, 2015. |
Office action for co-pending U.S. Appl. No. 13/702,144 (6 pages)—dated Jan. 10, 2014. |
Office action for co-pending U.S. Appl. No. 13/702,144 (7 pages)—dated Jul. 29, 2014. |
Office action for co-pending U.S. Appl. No. 13/823,818 (9 pages)—dated Mar. 26, 2015. |
Office action for co-pending U.S. Appl. No. 13/866,368 (16 pages)—dated Aug. 29, 2013. |
Office action for co-pending U.S. Appl. No. 13/866,368 (11 pages)—dated Apr. 16, 2014. |
Office action for co-pending U.S. Appl. No. 13/866,368 (8 pages)—dated Aug. 21, 2014. |
Office action for co-pending U.S. Appl. No. 13/866,419 (14 pages)—dated Sep. 20, 2013. |
Office action for co-pending U.S. Appl. No. 13/866,419 (10 pages)—dated Apr. 25, 2014. |
Office action for co-pending U.S. Appl. No. 13/866,419 (8 pages)—dated Oct. 9, 2014. |
Office action for co-pending U.S. Appl. No. 13/866,419 (8 pages)—dated Sep. 25, 2015. |
Office action for co-pending U.S. Appl. No. 13/868,233 (23 pages)—dated Aug. 13, 2013. |
Office action for co-pending U.S. Appl. No. 13/868,233 (12 pages)—dated Apr. 15, 2014. |
Office action for co-pending U.S. Appl. No. 13/868,233 (8 pages)—dated Oct. 7, 2014. |
Office action for co-pending U.S. Appl. No. 13/868,233 (8 pages)—dated Jul. 16, 2015. |
Office action for co-pending U.S. Appl. No. 13/868,238 (8 pages)—dated Jul. 16, 2014. |
Office action for co-pending U.S. Appl. No. 12/976,379 (7 pages)—dated Jan. 10, 2012. |
Office action for co-pending U.S. Appl. No. 12/976,379 (6 pages)—dated Jul. 27, 2012. |
Office action for co-pending U.S. Appl. No. 12/976,379 (9 pages)—dated Mar. 7, 2013. |
Office action for co-pending U.S. Appl. No. 12/976,379 (8 pages)—dated Aug. 20, 2013. |
Office action for co-pending U.S. Appl. No. 12/599,858 (8 pages)—dated May 11, 2011. |
Office action for co-pending U.S. Appl. No. 13/341,542 (8 pages)—dated Dec. 26, 2012. |
Office action for co-pending U.S. Appl. No. 13/341,542 (7 pages)—dated Feb. 10, 2014. |
Office action for co-pending U.S. Appl. No. 14/026,394 (6 pages)—dated Aug. 14, 2014. |
Office action for co-pending U.S. Appl. No. 14/272,556 (14 pages)—dated Nov. 20,2014. |
Office action for co-pending U.S. Appl. No. 14/272,556 (12 pages)—dated Sep. 17, 2015. |
Office action for co-pending U.S. Appl. No. 14/342,069 (17 pages)—dated Dec. 29, 2015. |
Office action for co-pending U.S. Appl. No. 14/342,069 (22 pages)—dated Sep. 2, 2016. |
Office action for co-pending U.S. Appl. No. 14/342,069 (21 pages)—dated Sep. 26, 2017. |
Office action for co-pending U.S. Appl. No. 14/342,069 (21 pages)—dated Jun. 6, 2018. |
Office action for co-pending U.S. Appl. No. 14/649,277 (9 pages)—dated Jul. 22, 2016. |
Office action for co-pending U.S. Appl. No. 14/686,915 (8 pages)—dated Nov. 18, 2016. |
Office action for co-pending U.S. Appl. No. 14/810,765 (7 pages)—dated Jan. 29, 2016. |
Office action for co-pending U.S. Appl. No. 14/828,916 (8 pages)—dated Nov. 25, 2016. |
Office action for co-pending U.S. Appl. No. 14/867,502 (9 pages)—dated Nov. 18, 2016. |
Office action for co-pending U.S. Appl. No. 15/172,432 (16 pages)—dated Apr. 17, 2017. |
Office action for co-pending U.S. Appl. No. 15/702,087 (5 pages)—dated Nov. 9, 2018. |
Office action for co-pending U.S. Appl. No. 15/177,442 (17 pages)—dated May 19, 2017. |
Office action for co-pending U.S. Appl. No. 15/378,159 (18 pages)—dated Mar. 2, 2017. |
Office action for co-pending U.S. Appl. No. 15/222,122 (8 pages)—dated Nov. 20, 2017. |
Office action for co-pending U.S. Appl. No. 15/310,837 (13 pages)—dated Jun. 21, 2018. |
Office action for co-pending U.S. Appl. No. 15/411,972 (9 pages)—dated Mar. 28, 2017. |
Office action for co-pending U.S. Appl. No. 15/411,972 (8 pages)—dated Nov. 29, 2017. |
Office action for co-pending U.S. Appl. No. 15/411,972 (9 pages)—dated Jun. 14, 2018. |
Office action for co-pending U.S. Appl. No. 15/116,254 (8 pages)—dated Apr. 26, 2018. |
Office action for co-pending U.S. Appl. No. 15/116,254 (10 pages)—dated Aug. 15, 2018. |
Office action for co-pending U.S. Appl. No. 15/333,670 (5 pages)—dated Dec. 8, 2017. |
Office Action for co-pending U.S. Appl. No. 14/116,048 (10 pages)—dated Jun. 23, 2017. |
Office action for co-pending U.S. Appl. No. 15/959,131 (8 pages)—dated Nov. 8, 2019. |
Office action for co-pending U.S. Appl. No. 15/822,102 (6 pages)—dated Dec. 6, 2019. |
Office action for co-pending U.S. Appl. No. 15/690,623 (6 pages)—dated Jan. 9, 2020. |
Other Information—Narrative of verbal disclosure of Brian Swift (1 page)—May 13, 2014. |
Petition for Inter Partes Review of U.S. Pat. No. 8,114,210 (52 pages, filed Jun. 12, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,114,210 (58 pages, filed Jun. 12, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with Petition for Inter Partes Review of U.S. Pat. No. 8,114,210). |
1st Petition for Inter Partes Review of U.S. Pat. No. D. 631,670 (68 pages, filed Jun. 19, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
2nd Petition for Inter Partes Review of U.S. Pat. No. D. 631,670 (62 pages, filed Nov. 2, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Decision of PTAB regarding Institution of Inter Partes Review for U.S. Pat. No. D. 631,670 (33 pages)—Jan. 12, 2016. |
Decision2 of PTAB regarding Institution of Inter Partes Review for U.S. Pat. No. D. 631,670 (27 pages)—May 9, 2016. |
Final Written Decision of PTAB regarding Inter Partes Review of U.S. Pat. No. D. 631,670 based on 1st Petition (56 pages)—Jan. 11, 2017. |
Final Written Decision of PTAB regarding Inter Partes Review of U.S. Pat. No. D. 631,670 based on 2nd Petition (55 pages)—May 8, 2017. |
Court of Appeals for Federal Circuit Judgment from Appeal of PTAB Decisions in Inter Partes Reviews of U.S. Pat. No. D. 631,670 (2 pages)—Jul. 13, 2018. |
1st Petition for Inter Partes Review of U.S. Pat. No. 8,940,089 (61 pages, filed Jul. 1, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,940,089 (70 pages, filed Jul. 1, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. In connection with 1st Petition for Inter Partes Review of U.S. Pat. No. 8,940,089). |
2nd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089 (56 pages, filed Jul. 10, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,940,089 (67 pages, filed Jul. 10, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 2nd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089). |
3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089 (62 pages, filed Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,940,089 (76 pages, filed Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089). |
Declaration of Dr. Elam Leed (11 pages, filed Jul. 1, Jul. 10, and Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089, respectively). |
Declaration of Dr. Jonathan Vickers (10 pages, filed Jul. 1, Jul. 10, and Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089, respectively). |
1st Petition for Inter Partes Review of U.S. Pat. No. 9,039,827 (60 pages, filed Jul. 29, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 9,039,827 (72 pages, filed Jul. 29, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st Petition for Inter Partes Review of U.S. Pat. No. 9,039,827). |
2nd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827 (51 pages, filed Aug. 5, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 9,039,827 (65 pages, filed Aug. 5, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 2nd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827). |
3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827 (57 pages, filed Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 9,039,827 (75 pages, filed Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827). |
Declaration of Dr. Elam Leed (11 pages, filed Jul. 29, Aug. 5, and Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827, respectively). |
Declaration of Dr. Jonathan Vickers (10 pages, filed Jul. 29, Aug. 5, and Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827, respectively). |
Petition for Inter Partes Review of U.S. Pat. No. 9,469,747 (67 pages, filed Mar. 20, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Petition for Inter Partes Review of U.S. Pat. No. 9,828,287 (86 pages, filed Mar. 23, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Petition for Inter Partes Review of U.S. Pat. No. 9,464,207 (78 pages, filed Mar. 28, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Petition for Inter Partes Review of U.S. Pat. No. 9,926,464 (74 pages, filed Mar. 30, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.). |
Office Action Granting Ex Parte Reexamination of U.S. Pat. No. 7,888,445, dated Dec. 24, 2013, in Control No. 90/013,029, 11 pages. |
Office Action Granting Ex Parte Reexamination of U.S. Pat. No. 7,772,347, dated Dec. 24, 2013, in Control No. 90/013,030, 14 pages. |
Office Action Granting Ex Parte Reexamination of U.S. Pat. No. 7,854,980, dated Apr. 15, 2014, in Control No. 90/013,156, 20 pages. |
Declaration of Jan Rud Andersen submitted in Ex parte Reexamination Control No. 90/013,030, as Document OTH-C, Oct. 10, 2013, 4 pages. |
Final Rejection in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (20 pages)—Jul. 24, 2015. |
Final Rejection in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (23 pages)—Jul. 24, 2015. |
Final Rejection in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (31 pages)—Aug. 18, 2015. |
Advisory Action in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (4 pages)—Oct. 6, 2015. |
Advisory Action in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (4 pages)—Oct. 6, 2015. |
Advisory Action in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (4 pages)—Nov. 18, 2015. |
Examiner's Answer in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (8 pages)—Mar. 23, 2016. |
Examiner's Answer in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (8 pages)—Mar. 23, 2016. |
Examiner's Answer in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (8 pages)—Mar. 22, 2016. |
Decision of PTAB in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (17 pages)—Sep. 29, 2016. |
Decision of PTAB in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (18 pages)—Sep. 29, 2016. |
Decision of PTAB in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (22 pages)—Sep. 30, 2016. |
Court of Appeals for Federal Circuit Judgment from Consolidated Appeal of PTAB Decisions in Ex Parte Reexamination of U.S. Pat. Nos. 7,888,445, 7,772,347 and 7,854,980 (5 pages)—Mar. 9, 2018. |
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 7,772,347 (4 pages)—Oct. 24, 2018. |
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 7,888,445 (4 pages)—Dec. 7, 2018. |
Notice of Intent to Issue Inter Partes Reexamination Certificate for U.S. Pat. No. 7,888,445 (14 pages)—Sep. 24, 2020. |
Notice of Intent to Issue Inter Partes Reexamination Certificate for U.S. Pat. No. 7,772,347 (13 pages)—Sep. 25, 2020. |
Decision of USPTO to Reopen Prosecution in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (7 pages)—Jan. 7, 2019. |
Non-final Office Action from Reopened Prosecution in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (26 pages)—dated Apr. 3, 2019. |
Final Office Action from Reopened Prosecution in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (11 pages)—dated Aug. 8, 2019. |
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 7,854,980 (3 pages)—Oct. 29, 2019. |
Notice of Intent to Issue Inter Partes Reexamination Certificate for U.S. Pat. No. 7,807,771 (4 pages)—Jan. 30, 2014. |
Notice of Intent to Issue Inter Partes Reexamination Certificate for U.S. Pat. No. 7,854,980 (6 pages)—Aug. 31, 2017. |
Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (34 pages)—May 1, 2015. |
Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (36 pages)—May 1, 2015. |
Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,854,980 (25 pages)—Jul. 30, 2015. |
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (5 pages)—Dec. 9, 2015. |
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (5 pages)—Dec. 9 , 2015. |
Examiner's Determination on Patent Owner Response/Requester Comments after Board Decision in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (22 pages)—Oct. 17, 2016. |
Examiner's Determination on Patent Owner Response/Requester Comments after Board Decision in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (17 pages)—Oct. 17, 2016. |
Court of Appeals for Federal Circuit Opinion/Judgment from Appeal of PTAB Decision in Inter Partes Reexamination of U.S. Pat. No. 7,854,980 (13 pages)—Feb. 27, 2017. |
Final Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (25 pages)—Sep. 8, 2017. |
Final Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (24 pages)—Sep. 8, 2017. |
Decision of PTAB re Request for Rehearing in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (7 pages)—Feb. 12, 2018. |
Decision of PTAB re Request for Rehearing in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (7 pages)—Feb. 12, 2018. |
Court of Appeals for Federal Circuit Decision re Consolidated Appeal of PTAB Decision in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 and U.S. Pat. No. 7,888,445 (14 pages)—Oct. 15, 2019. |
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (3 pages)—Jul. 1, 2020. |
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (3 pages)—Jul. 1, 2020. |
Decision of PTAB regarding Institution of Inter Partes Review for U.S. Pat. No. 8,114,210 (20 pages)—Oct. 21, 2015. |
Final Written Decision of PTAB regarding Inter Partes Review of U.S. Pat. No. 8,114,210 (39 pages)—Oct. 19, 2016. |
Court of Appeals for Federal Circuit Judgment from Appeal of PTAB Decision in Inter Partes Review of U.S. Pat. No. 8,114,210 (5 pages)—Jan. 16, 2018. |
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 8,114,210 (11 pages)—Apr. 9, 2020. |
Decision1 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 8,940,089 (16 pages)—Dec. 17, 2015. |
Decision2 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 8,940,089 (19 paages)—Dec. 17, 2015. |
Decision3 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 8,940,089 (14 pages)—Dec. 17, 2015. |
Decision1 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 9,039,827 (16 pages)—Jan. 4, 2016. |
Decision2 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 9,039,827 (19 pages)—Jan. 4, 2016. |
Decision3 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 9,039,827 (14 pages)—Jan. 4, 2016. |
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,926,464 (29 pages)—Oct. 2, 2018. |
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,464,207 (28 pages)—Oct. 2, 2018. |
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,469,747 (29 pages)—Oct. 3, 2018. |
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,828,287 (22 pages)—Oct. 16, 2018. |
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,828,287 (13 pages)—Jul. 17, 2020. |
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,464,207 (14 pages)—Jul. 31, 2020. |
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,926,464 (18 pages)—Aug. 5, 2020. |
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 8,940,089 (17 pages)—Oct. 16, 2020. |
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,039,827 (16 pages)—Oct. 16, 2020. |
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,469,747 (16 pages)—Nov. 9, 2020. |
Statement of Revocation Grounds re GB2496951—Claimant Rockwool International (May 21, 2018, 22 pages). |
Statement of Revocation Grounds re GB2451719—Claimant Rockwool International (May 18, 2018, 22 pages). |
Expert Report re Revocation of GB2451719 and GB2496951—Claimant Rockwool International (Nov. 12, 2018, 11 pages). |
United Kingdom Intellectual Property Office, Decision in Rockwool International v. Knauf Insulation Limited, Application under Section 72 for revocation of patents GB2451719 and GB2496951 (May 28, 2019—18 pages). |
Decision of EPO Board of Appeal re Added Matter vis-à-vis EP06788492.4 (Jul. 17, 2019—14 pages). |
U.S. Pat. No. 2,965,504—Part 1 (10 pages). |
U.S. Pat. No. 2,965,504—Part 2 (14 pages). |
U.S. Pat. No. 2,965,504—Part 3 (14 pages). |
Gogek Attorney Comments re U.S. Pat. No. 2,965,504—Apr. 6, 1960 (3 pages). |
Gogek Affidavit Under Rule 132 re U.S. Pat. No. 2,965,504—Feb. 26, 1960 (3 pages). |
Number | Date | Country | |
---|---|---|---|
20190257078 A1 | Aug 2019 | US |